Retroviral vectors expressing tumor necrosis factor (TNF)

Chemistry: molecular biology and microbiology – Treatment of micro-organisms or enzymes with electrical or... – Modification of viruses

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

4353201, 435366, 435372, 424 932, 424 9321, C12N 1586, C12N 1519, C12N 1527, C12N 1528

Patent

active

056521308

ABSTRACT:
A drug delivery virion which contains an expression system for the desired protein active ingredient packaged in an envelope derived from a retrovirus is especially useful in administering materials which need to cross cell membranes in order to serve their function.

REFERENCES:
patent: 4405712 (1983-09-01), Woude et al.
patent: 4603112 (1986-07-01), Paoletti et al.
patent: 4650764 (1987-03-01), Temin et al.
patent: 4663281 (1987-05-01), Gillies et al.
patent: 4677063 (1987-06-01), Mark et al.
patent: 4708818 (1987-11-01), Montanier et al.
patent: 4725669 (1988-02-01), Essex et al.
patent: 4769330 (1988-09-01), Paoletti et al.
patent: 4839284 (1989-06-01), Kern et al.
patent: 4868116 (1989-09-01), Morgan et al.
patent: 4879226 (1989-11-01), Wallace et al.
patent: 4980286 (1990-12-01), Morgan et al.
patent: 5091309 (1992-02-01), Schesinger et al.
Anderson, W.F., "Prospects for Human Gene Therapy," Science, 226:401-409 (Oct. 26, 1984).
Bender et al., "Evidence that the Packaging Signal of Maloney Murine Leukemia Virus Extends into the gag Region," J. Virol., 61(5):1639-1646 (May, 1987).
Clewell, D.B., "Nature of Col E.sub.1 Plasmid Replication in Escherichia coli in the Presence of Chloramphenicol," J. Bacteriol., 110(2):667-676 (May, 1972).
Clewell et al., "Supercoiled Circular DNA-Protein Complex Escherichia coli: Purification and Induced Conversion to an Open Circular DNA Form," Proc. Nat'l Acad. Sci., USA, 62:1159-1166 (1969).
Coffin, J., Genome Structure, In: RNA Tumor Viruses, vol. 2, Weiss et al., (Eds.), 2nd Edition, Cold Spring harbor Monograph Series, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, pp. 17-73.
Cohen et al., "Nonchromosomal Antibiotic Resistance in Bacteria: Genetic Transformation of Escherichia coli by R-Factor DNA," Proc. Nat'l Acad. Sci., USA, 69(8):2110-2114 (Aug., 1972).
Cone et al., "High-efficiency Gene Transfer into Mammalian Cells: Generation of Helper-free Recombinant Retrovirus With Broad Mammalian Host Range," Proc. Nat'l Acad. Sci., USA, 81:6349-6353 (Oct., 1984).
Friedmann, "Progress Toward Human Gene Therapy," Science, 244:1275-1281 (1989).
Gillio et al., "Retroviral Vector-mediated Gene Transfer and Expression in Nonhuman Primates Following Autologous Bone Marrow Transplantation," Annals of the NY Acad. of Sci., Part V:406-417 (1987).
Hock et al., "Retrovirus-mediated Transfer and Expression of Drug Resistance Genes in Human Haematopoietic Progenitor Cells," Nature, 320:275-277 (1986).
Joyner et al., "Retrovirus Transfer of a Bacterial Gene into Mouse Haematopietic Progentior Cells," Nature, 305:556-558 (1983).
Kriegler et al., "Transformation Mediated by the SV40 T Antigens: Separation of the Overlapping SV40 Early Genes with a Retroviral Vector," Cell, 38:483-491 (Sep., 1984).
Lang et al., "Expression of a Hemopoietic Growth Factor cDNA in a Factor-Dependent Cell Line Results in Autonomous Growth and Tumorigenicity," Cell, 43:531-542 (Dec., 1985).
Ledley et al., "Retroviral-medicated Gene Transfer of Human Phenylalanine Hydroxylase into NIH 3T3 and Hepatoma Cells," Proc. Nat'l Acad. Sci., USA, 83:409-413 (1986).
Maniatis et al., Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, pp. 252-253 (1982).
Mann et al., "Construction of a Retrovirus Packaging Mutant and Its Use to Produce Helper-Free Defective Retrovirus," Cell, 33:153-159 (May, 1983).
Matteucci et al., "Synthesis of Deoxyoligonucleotides on a Polymer Support," J. Am. Chem. Soc., 103:3185-3191 (1981).
Maxam et al., "Sequencing End-Labeled DNA with Base-Specific Chemical Cleavages," Meth. Enzymol., 65:499-561 (1980).
McCormick,D., "Human Gene Therapy: The First Round," Bio/Technology, 3:689-693 (1985).
Miller et al., "Improved Retroviral Vectors for Gene Transfer and Expression," BioTechniques, 7(9):980-988 (1989).
Sanger et al., "DNA Sequencing with Chain-Terminating Inhibitors," Proc. Nat'l Acad. Sci. USA, 74(12):5463-5467 (Dec., 1977).
Southern et al., "Transformation of Mammalian Cells to Antibiotic Resistance with a Bacterial Gene Under Control of the SV40 Early Region Promotor," J. Mol. Appl. Gen., 1:327-341 (1982).
Wang et al., "Molecular Cloning of the Complementary DNA for Human Tumor Necrosis Factor," Science, 228:149-154 (Apr. 12, 1985).
Zwiebel et al., "High-Level Recombinant Gene Expression in Rabbit Endothelial Cells Transduced by Retroviral Vectors," Science, 243:220-222 (1989).
Bolognesi et al., "Prospects of Treatment of Human Retrovirus-Associated Diseases," Cancer Research, Supplement, 45:4700s-4705s (1985).
Carr et al., "Genetic Transformatin of Murine Bone Marrow Cells to Methotrexate Resistance," Blood, 62(1):180-185 (1983).
Chakrabarti et al., "Expression of the HTLV-III Envelope Gene by a Recombinant Vaccinia Virus," Nature, 320:535-537 (1986).
Cline et al., "Gene Transfer in Intact Animals," Nature, 284:422-425 (1980).
Cortes et al., "Successful Immunotherapy in a Murine Metastasizing Fibrosarcoma Model," J. Surg. Onco., 25:289-295 (1984).
De Baetselier et al., "Differential Expression of H-2 Gene Products in Tumour Cells is Associated with Their Metastatogenic Properties," Nature, 288:179-181 (Nov. 13, 1980).
Donner et al., "McDonough Feline Sarcoma Virus: Characterization of the Molecularly Cloned Provirus and Its Feline Oncogene (v-fins)," J. Virol, 41(2):489-500 (1982).
Episkopou et al., "Cell-specified Expression of a Selectable Hybrid Gene," Proc. Nat'l Acad. Sci., USA, 81:4657-4661 (1984).
Friedmann, T., "The Future For Gene-Therapy-A Reevaluation," Ann. N.Y. Acad. Sci., 265:141-152 (1975).
Gruber et al., "Retroviral Vector-Mediated Gene Transfer into Human Hematopoietic Progenitor Cells," Science, 230:1057-1061 (1985).
Hellerman et al., "Secretion of Human Parathyroid Hormone From Rat Pituitary Cells Infected With a Recombinant Retrovirus Encoding Preproparathyroid Hormone," Proc. Nat'l Acad. Sci., USA, 81:5340-5344 (1984).
Holt et al., "Inducible Production of c-fos Antisense RNA Inhibits 3T3 Cell Proliferation," Proc. Nat'l Acad. Sci., USA, 83:4794-4798 (1986).
Izant and Weintraub, "Constitutive and Conditional Suppression of Exogenous and Endogenous Genes by Anti-Sense RNA," Science, 229:345-352 (1985).
Joyner et al., "Construction and Transfer of Recombinant Retrovirus Clones Carrying the HSV-1 Thymidine Kinase Gene," The Ontario Cancer Institute, Department of Medical Biophysics, University of Toronto, Toronto, Canada, Developmental Biology Using Purified Genes, pp. 535-546 (1981).
Keller et al., "Expression of a Foreign Gene in Myeloid and Lymphoid Cells Derived From Multipotent Haematopoietic Precursors," Nature, 318:149-154 (1985).
Lee, R.E., "Gene Therapy: Clipping the Wings of Nature's Own Gene Transfer Vectors," Can. Med. Assoc. J., 134:311-313 (Feb. 15, 1986).
Linial et al., "An Avian Oncovirus Mutant (SE 21Q1b) Deficient in Genomic RNA: Biological and Biochemical Characterization," Cell, 15:1371-1381 (1978).
Linial, M., "Transfer of Defective Avian Tumor Virus Genomes by a Rous Sarcoma Virus RNA Packaging Mutant," J. Virology, 38(1):380-382 (Apr., 1981).
Mason et al., "The Hypogonadal Mouse: Reproductive Functions Restored by Gene Therapy," Science, 234:1372-1378 (1986).
McAleer et al., "Human Hepatitis B Vaccine from Recombinant Yeast," Nature, 307:178-180 (1984).
McMichael et al., "Cytotoxic T-Cell Immunity to Influenza," The New England J. Med., 309:13-17 (1983).
Mercola et al., "Insertion of a New Gene of Viral Origin into Bone Marrow Cells of Mice," Science, 208:1033-1035 (1980).
Miller et al., "Expression of a Retrovirus Encoding Human HPRT in Mice," Science, 225:630-632 (1984).
Miller et al., "Generation of Helper-Free Amphotropic Retroviruses That Transduce a Dominant -Acting, Methotrexate-Resistant Dihydrofolate Reductase Gene," Mol. And Cell. Biol., 5(3):431-437 (1985).
Miller et al., "A Transmissible Retrovirus Expressing Human Hypoxanthine Phosphoribosyltransferase (HPRT): Gene Transfer into Cells Obtained From Humans Deficient in HPRT," Proc. Nat'l Acad. Sci., USA, 80:4709-4713 (1983).
Morrow, J.F., "The Prospects for Gene Therapy in Humans," Ann. N.Y. Acad.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Retroviral vectors expressing tumor necrosis factor (TNF) does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Retroviral vectors expressing tumor necrosis factor (TNF), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Retroviral vectors expressing tumor necrosis factor (TNF) will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-632855

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.